AMPAC re-opens 50,000 gallon API facility in Virginia

By Maggie Lynch

- Last updated on GMT

(Image: Getty/PBFloyd)
(Image: Getty/PBFloyd)

Related tags API facility Investment Ampac Manufacturing analytical

After being acquired by SK Holdings, AMPAC re-opens its API manufacturing facility in Virginia as part of a growing investment in its US capabilities.

AMPAC Fine Chemicals (AFC) re-opened its manufacturing operations at its active pharmaceutical ingredient (API) facility in Petersburg, US, after the site saw infrastructure refurbishment.

According to AFC, the pharmaceutical ingredients manufactured at the plant will be for pharmaceutical companies across the US and will be used in the production of treatments for central nervous system deficiencies, cancer, and epilepsy.

The expansion of the US-based company’s operations comes shortly after it was acquired as a portfolio company by SK holdings, an investment holding company of the South Korean SK Group.

The Petersburg site encompasses around 200 acres of the city’s industrial complex and has a 50,000-gallon capacity. With the re-opening, 100 jobs are expected to generate over the next few years.

AFC president and CEO, Aslam Malik, said in a statement that the re-opening of the plant demonstrates the company’s interest in employing more local residents, its growing investment in the US, and to create opportunities to develop community partnerships.

The company has operations in La Porte, Texas, Petersburg, Virginia, and both Rancho Cordova and El Dorado Hills, California. Its global offerings extend beyond technology platforms for API production including, continuous processes and industrial scale chromatographic separation, highly potent compound manufacturing, and analytical services.

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Follow us


View more